Raymond James Financial Inc Atossa Therapeutics, Inc. Transaction History
Raymond James Financial Inc
- $299 Billion
- Q3 2025
A detailed history of Raymond James Financial Inc transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 10,815 shares of ATOS stock, worth $8,760. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,815
Previous 12,815
15.61%
Holding current value
$8,760
Previous $10,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ATOS
# of Institutions
75Shares Held
26.8MCall Options Held
79.5KPut Options Held
98.8K-
Black Rock Inc. New York, NY9.2MShares$7.45 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.08MShares$4.92 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2.95MShares$2.39 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.67MShares$1.35 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.55MShares$1.25 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $103M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...